Avita Medical Inc.
- RCEL
- NASDAQ
- Medical devices
- Wound Care Devices (RECELL)
- Burn Treatment
$13.19
Today +1.15%Quote Oct 19, 2026, 07:39 PM UTC
+16.22%over the last month
Max drawdown −4.7%From 1-month high −2.8%3 months +153.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Avita Medical
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Where the money comes from
Q2 2026 revenue $21.7M
- Recell System$19.0M87.8%
- Lease Revenue$213,0001.0%
- Other / not reported$2.4M11.2%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
226
Market value
$407.9M
Quote Oct 19
Floor
$13.10
0.7% below price
Resistance
$13.73
4.1% above price
Price vs analyst targets
8 analysts
Lowest target
$11.00Highest target
$12.00
$11.00Highest target
$12.00
- Price $13.19
- Average target $11.50
- Analysts' target range
The price is above even the highest analyst target. Analysts' average target sits about 13% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RCELPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free